Activity Stream
Tetrahydrocannabinol Market Leaders to face stronger headwinds from Emerging Players
Global Tetrahydrocannabinol Market, Tetrahydrocannabinol Market Demand, Tetrahydrocannabinol Market Trends, Tetrahydrocannabinol Market Analysis, Tetrahydrocannabinol Market Growth, Tetrahydrocannabinol Market Share, Tetrahydrocannabinol Market Forecast, Tetrahydrocannabinol Market Challenges
Advance Market Analytics released a new market study on Global Tetrahydrocannabinol Market Research report which presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for Global Tetrahydrocannabinol Forecast till 2030*.
Tetrahydrocannabinol is referred to as principal active ingredients in marijuana. In the United States, marijuana still remains the most repeatedly abused illicit drug, though its popularity appears to cycle, trending up and down over decades. THC is classified as a mild sedative at low doses and a hallucinogen at high doses. According to the National Institute on Drug Abuse (NIDA), it acts much like the cannabinoid chemicals made naturally by the body. THC attaches to these receptors and activates them and affects a person's memory, pleasure, coordination, movements, thinking, concentration, and sensory and time perception, according to NIDA. Its anti-emetic properties (inhibits vomiting) are particularly useful in the treatment of cancer patients on chemotherapy. Also, as THC increases the appetite and reduces the vomit response, it is starting to be used in the treatment of anorexia and other eating disorders.
GET FREE SAMPLE PDF ON Tetrahydrocannabinol MARKET
Key Players included in the Research Coverage of Tetrahydrocannabinol Market are:
MedReleaf Corporation (Canada), Aurora Cannabis Inc. (Canada), BOL Pharma (Israel), Tilray (Canada), Medreleaf Corporation (Canada), Aurora Cannabis, Inc. (Canada) , Green Relief Inc. (Canada), Canopy Growth Corporation (Canada), Insys Therapeutics, Inc. (United States), Aphria, Inc. (Canada),
What's Trending in Market: Health Safety in Cannabis Products
Legalization of Medicinal Cannabis in Various Economies
Challenges: Straighten Government Regulations
Opportunities: Huge Demand due to Use in Healthcare Industry
Emerging Demand from Economies
Market Growth Drivers: Growing Research and Development Activities
High Public and Private Investments in Research and Developments
The Global Tetrahydrocannabinol Market segments and Market Data Break Down by Application (Chronic Pain, Mental Disorders, Arthritis, Migraine, Cancer, Other), Distribution Channel (Hospital Pharmacy, Dispensaries, Online Pharmacy)
Read Detailed Index of full Research Study at @
To comprehend Global Tetrahydrocannabinol market dynamics in the world mainly , the worldwide Tetrahydrocannabinol market is analyzed across major global regions. AMA also provides customized specific regional and country-level reports for the following areas.
- North America: United States, Canada, and Mexico.
- South & Central America: Argentina, Chile, Colombia and Brazil.
- Middle East & Africa: Saudi Arabia, United Arab Emirates, Israel, Turkey, Egypt and South Africa.
- Europe: United Kingdom, France, Italy, Germany, Spain, Belgium, Netherlands and Russia.
- Asia-Pacific: India, China, Japan, South Korea, Indonesia, Malaysia, Singapore, and Australia.
For More Information Please Connect: AMA Research & Media LLP
Presented By
AMA Research & Media LLP
Contact US:
Craig Francis (PR & Marketing Manager)
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: (+1 201 565 3262, +44 161 818 8166)
sales@advancemarketanalytics.com
